Permitted material2
1
All relevant material (within the meaning given by section 53 of the Human Tissue Act 2004) is specified as permitted material for the purposes of section 3(6AA) of that Act; but this is subject to paragraphs (2) and (5).
2
Except as provided by paragraphs (3) and (4), the whole or any part of the following is not permitted material—
a
arm;
b
brain;
c
face;
d
finger;
e
foot;
f
forearm;
g
hand;
h
leg;
i
lower leg;
j
mouth;
k
nose;
l
spinal cord;
m
thigh;
n
toe;
o
trachea;
p
upper arm;
q
cervix;
r
clitoris;
s
embryo (inside the body)4;
t
fallopian tube;
u
foetus;
v
labia;
w
ovary;
x
penis;
y
perineum;
z
placenta;
aa
prostate;
bb
testicle;
cc
umbilical cord;
dd
uterus;
ee
vagina;
ff
vulva.
3
The following tissue does not fall within paragraph (2) in so far as it is disaggregated from any of the relevant material specified in sub-paragraphs (a) to (p) of that paragraph (and, accordingly, such tissue is permitted material)—
a
artery;
b
bone;
c
muscle;
d
nervous tissue;
e
skin;
f
tendon.
4
The whole or part of the trachea does not fall within paragraph (2) in so far as it is attached to a lung (and, accordingly, such tissue is permitted material).
5
The following types of cells are not permitted material in so far as all or part of the cells is for use in, or as, an advanced therapy medicinal product—
a
limbal stem cells;
b
liver cells;
c
lung epithelial cells;
d
pancreatic cells;
e
renal epithelial cells.
6
In this regulation, “advanced therapy medicinal product” has the same meaning as in the Human Medicines Regulations 20125.